-
Volume 74,
Issue 6,
2025
Volume 74, Issue 6, 2025
- Editorials
-
- Commentaries
-
-
-
SARS-CoV-2 and neurotropism: evidence, gaps and reflections
More LessCoronavirus disease 2019 (COVID-19) patients may present with a wide clinical spectrum, including extrapulmonary involvement, such as neurological damage. Although the pathogenesis of neurological COVID-19 still remains unclear, some studies have discussed the potential association between tissue injury and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) infection in the central nervous system (CNS) and/or immune imbalance. These two mechanisms are non-mutually exclusive; however, exacerbated inflammatory-response-induced neurological damage appears to be more aligned with COVID-19 pathogenesis, whereas SARS-CoV-2 infection/replication in the CNS remains widely discussed. Herein, we dissect this last issue, highlighting some evidence on SARS-CoV-2 neuroinvasion, as well as discussing gaps that should be addressed for a better understanding of its potential neurotropism, specifically in the CNS. Finally, we propose some deeper reflections on the SARS-CoV-2 neurotropic potential.
-
-
-
-
The ability of ozone to counteract multidrug-resistant bacteria if used as an adjunct therapy: a bioinformatic modelling
More LessMultidrug-resistant (MDR) bacteria pose a growing threat to global health, prompting exploration of alternative therapies. This study uses bioinformatic modelling to assess ozone therapy as an adjunct treatment, analysing both linear and non-linear (chaotic) frameworks. Results suggest that ozone exerts bactericidal effects and modulates immune responses, partly through the production of 4-hydroxynonenal. Simulations indicate that ozone-induced adaptive chaos may enhance immune resilience and accelerate bacterial clearance compared to antibiotics alone. However, the findings are theoretical, and the short half-life of ozone limits direct impact, emphasizing the need for experimental validation. Ozone therapy shows promise, but its role in adaptive chaos requires further study to determine its clinical viability, despite a large number of reports showing an undisputable action of medical ozone against MDR bacteria.
-
- Reviews
-
-
-
Extended-spectrum beta-lactamases: definition, history, an update on their genetic environment and detection methods
More LessBacterial resistance remains a major challenge in the therapeutic field. Beta-lactam antibiotics are widely used to treat Enterobacteriaceae, especially third-generation cephalosporins (3GCs), which are used in infections caused by bacteria resistant to first- and second-line antibiotics. However, these bacteria have been able to develop resistance against the used antibiotics through the production of extended-spectrum beta-lactamase (ESBL) enzymes. These enzymes inactivate 3GCs and are sensitive to beta-lactamase inhibitors such as clavulanic acid. This resistance is acquired by plasmids (IncF, IncI, IncK…) which carry mobile genetic elements (insertion sequence, transposon…) with genes coding for these enzymes, namely, the bla CTX-M, bla SHV and bla TEM, which code for the most frequent types of ESBL (CTX-M, SHV and TEM). Unfortunately, when ESBLs are not identified in time, appropriate treatment is delayed, reducing the chances of cure. Current data highlight the spread and dangerousness of ESBL-producing bacteria worldwide and confirm the priority given to these bacteria by the World Health Organization, which insists on vigilance in identifying them, both in patients and through surveillance studies. The aim of the current review is to provide a better understanding of ESBLs, to highlight their historical evolution and to show the importance of their genetic environment in the dissemination and spread of these enzymes worldwide, as well as the techniques used to detect them in laboratory studies. Current data demonstrate the degree of danger posed by ESBL-producing bacteria and confirm the priority given to these bacteria by the World Health Organization for the development of new antimicrobial agents.
-
-
- Antimicrobial Resistance
-
-
-
Trimethoprim resistance in Escherichia coli exhibits an allele-specific growth advantage
More LessIntroduction. The antibiotic trimethoprim has been used to treat urinary tract infection (UTI) since ~1962. Alongside the nitrofurantoin, there are still justified reasons for trimethoprim use, especially in non-pregnant women. Trimethoprim resistance is commonly the result of acquiring the trimethoprim-insensitive dihydrofolate reductase gene: dfrA. Assessment of clinical Escherichia coli isolates from two clinical trials, AnTIC and ALTAR, identified carriage of two copies of dfrA.
Hypothesis. The hypothesis tested here was that dual dfrA carriage provided E. coli with a growth advantage.
Methodology. Two hundred and seventy-eight clinical isolates from AnTIC/ALTAR were assessed for dfrA carriage. Microplate-based growth assays assessed growth behaviour with and without 64 mg l−1 trimethoprim. Allelic replacement of dfrA5 with five other alleles was also performed.
Results. One hundred and four isolates (37%) were identified to carry a total of 112 dfrA genes. Eight isolates (2.9%) carried two copies of dfrA. Comparison of dfrA + to dual dfrA carriage could be differentiated by their growth behaviour when exposed to trimethoprim but had comparable MIC (>512 mg l−1). Analysis of all dfrA + isolates determined that the growth behaviour exhibited an allelic bias. Allelic replacement of dfrA5 with dfrA1, dfrA7, dfrA8, dfrA14 and dfrA17 demonstrated that the growth behaviour was dfrA specific.
Conclusion. This analysis determined that the dual carriage of two dfrA alleles generated a growth advantage to E. coli. However, the growth behaviour was dictated by allele carriage and not specifically dual carriage, as single carriage isolates also possessed the identified phenotype. This data suggests that there is a potential clinical impact dictated by dfrA allele carriage that could improve clinical decisions on management strategies of UTI.
-
-
-
-
Antimicrobial efficacy of chlorhexidine-treated surfaces against clinical isolates implicated in nosocomial infections
More LessIntroduction. Bacterial infections and antimicrobial resistance are significant threats to global public health, both of which spread through contamination of solid surfaces. We have previously developed an antimicrobial surface technology that directly bonds the broad-spectrum biocide chlorhexidine to steel surfaces. These surfaces were shown to kill bacteria within minutes of contact and to be effective against bacteria evolved in the laboratory for resistance to chlorhexidine in solution.
Hypothesis/Gap Statement. We hypothesized that resistance to these surfaces could exist outside of the naive and chlorhexidine-resistant laboratory strains tested previously. We also sought to test whether strains that were resistant to chlorhexidine in solution were also resistant to chlorhexidine-based antimicrobial surfaces.
Aim. To test the efficacy of these surfaces against a range of bacteria isolated from the hospital environment and to compare this to the resistance of these bacteria to chlorhexidine in solution or when dissolved in solid media.
Methodology. Ninety-one isolates of mixed bacterial species were obtained from Queen Elizabeth Hospital Birmingham. The isolates, along with laboratory strains of Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus, were tested for sensitivity to chlorhexidine-coated steel surfaces in a 30-min exposure simulated splash assay. Resistance to chlorhexidine in solution was also assayed by solid and broth media MIC assays.
Results. We demonstrate that within 30 min of incubation, the surfaces reduced the survival of all 91 isolates. Over 85% of these isolates were killed (exhibiting a 7–8 log reduction compared with control surfaces), whilst 12% experienced a 3–4 log reduction. We also show that resistance to the surfaces did not correlate with resistance to freely diffusible chlorhexidine in liquid or solid media.
Conclusion. The results demonstrate the efficacy of chlorhexidine-coated surfaces against a broad range of bacterial isolates from the hospital environment and imply the potential for a mode of exposure to dictate the effectiveness of different antimicrobial resistance mechanisms. Future studies should investigate the genetic mechanisms providing resistance to chlorhexidine-coated surfaces and whether these differ in the capacity to provide resistance to chlorhexidine in different modes of exposure.
-
-
-
Improved diagnostic stewardship in carbapenem-resistant Enterobacterales gene detection helps in early initiation of targeted therapy
More LessIntroduction. Antimicrobial resistance (AMR) is an escalating global health crisis, leading to ~700,000 deaths annually. Without significant containment efforts, this number could surge to 10 million by 2050. Carbapenem-resistant organisms, particularly carbapenem-resistant Enterobacterales (CRE), Pseudomonas aeruginosa, and Acinetobacter baumannii, present a critical challenge due to their ability to evade potent carbapenem antibiotics.
Hypothesis and Aim. This study aimed to determine the prevalence of CRE among 1,317 culture-positive patients and to assess the impact of advanced diagnostic techniques, such as RT-PCR, modified carbapenem inactivation method (mCIM), EDTA carbapenem inactivation method (eCIM) and Vitek susceptibility testing, on improving diagnostic stewardship and patient outcomes.
Methodology. A retrospective cross-sectional study was conducted at Peerless Hospitex Hospital and Research Centre Limited, Kolkata, from June 2023 to May 2024. CRE isolates were identified from various clinical samples and subjected to phenotypic (Vitek 2, mCIM and eCIM) and genotypic real time polymerase chain reaction (RT-PCR) testing for carbapenemase genes. Data on demographics, specimen types, bacterial isolates, comorbidities, etc. were analysed.
Results. Out of 20,129 inpatient samples sent for culture during this 1-year period, 3,124 (15.51%) had culture-proven infections. A total of 1,317 Enterobacterales isolates were processed for carbapenem resistance (CR) detection PCR, with 354 (26.88%) identified as CRE. Klebsiella pneumoniae was the predominant isolate (60.17%), followed by Escherichia coli (26.55%). New Delhi metallo-β-lactamase (MBL) (NDM) and OXA-48-like co-production (33.75%) were most commonly seen, followed by NDM gene alone (32.50%). The concordance between phenotypic susceptibility and genotypic PCR method for CRE was 85.88%. Targeted antibiotic therapy could be initiated based on PCR results, in 70.90% of cases. Synergy test guided effective combination therapy of ceftazidime-avibactam and aztreonam for MBL-producing CRE isolates.
Conclusion. The study highlights a significant prevalence of CRE, particularly among older adults. Advanced diagnostic techniques improved diagnostic stewardship, allowing timely and accurate detection of CR. However, discrepancies between phenotypic and genotypic methods and the high cost of certain therapies are notable limitations. Enhanced infection control and early initiation of targeted therapy are crucial to combat AMR.
-
- Clinical Microbiology
-
-
-
Oral microbiota signatures in obesity with or without acanthosis nigricans in a Chinese cohort
More LessIntroduction. The oral microbiota is the second most complex microbial community in the human body. It has been suggested that poor oral health may be associated with an increased risk of obesity.
Hypothesis/Gap Statement. However, both previous observational and mechanistic studies on oral microbiota do not take into account the obesity-related acanthosis nigricans (AN), which is the most common dermatological manifestation in individuals with obesity.
Aim. This study aimed to investigate the altered composition, function and diagnostic value of the oral microbiota in obesity with or without acanthosis nigricans (AN).
Methodology. We characterized the oral bacteria signature in a Chinese cohort (ChiCTR2300073353) of 99 patients with obesity and obesity-related AN (Ob_AN) and 50 healthy controls using 16S rRNA gene V3–V4 region sequencing.
Results. The microbial richness (abundance-based coverage estimators and observed species indices) was significantly greater in the Ob_AN and obesity groups than in the control group; however, microbial diversity (Shannon index) did not differ significantly. Distinct separation in the microbial community amongst the three groups was observed. Prevotella species, including Prevotella melaninogenica, Prevotella nanceiensis and Prevotella pallens, were associated with composition alterations and predicted functions (significant downregulation of ATP-binding cassette transporters) associated with microbial dysbiosis in the obesity and Ob_AN groups. Moreover, Prevotella and Lautropia genera assessments could indicate obesity and obesity-related AN risk.
Conclusions. The notable reduction of plenty of oral microbiota and high levels of Prevotella spp. may play a critical role in obesity with AN. Oral microbiota may serve as biomarkers for diagnosing, preventing and even treating obesity-related AN.
-
-
-
-
Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada
More LessIntroduction. In cases where sputum is non-diagnostic or unavailable, bronchoscopy can yield high-value respiratory samples for tuberculosis (TB) diagnosis. Whilst Mycobacterium tuberculosis (MTB) complex culture remains the gold standard, molecular assays such as Xpert MTB/RIF Ultra (Xpert Ultra) are increasingly being used for rapid diagnosis.
Gap Statement. Xpert Ultra is increasingly used for TB diagnosis and has been extensively evaluated on sputum specimens, but assessment of performance on bronchoscopy samples is more limited.
Aim. To retrospectively evaluate the performance of Xpert Ultra on bronchoscopy specimens in comparison to culture in a low-incidence, high-resource setting.
Methodology. Patients with a clinical suspicion of TB, who had non-diagnostic sputum or limited sputum production and underwent bronchoscopy between March 2019 and October 2023, were included in the study. Bronchoscopy specimens comprised bronchoalveolar lavages, bronchial washings and endobronchial ultrasound lymph node tissue biopsies. All included specimens underwent acid-fast bacilli (AFB) smear, mycobacterial culture and Xpert Ultra. Positive MTB culture was considered the reference standard for TB diagnosis.
Results. One hundred thirty-five bronchoscopy samples from 126 patients were included. Cultures were positive for MTB in 47 out of 126 (37.3%) of included patients. Overall, positive percent agreement (PPA) and negative percent agreement (NPA) of Xpert Ultra to MTB culture were 93.6% and 98.7%, respectively. In 19 AFB smear-positive cases, Xpert Ultra had 100% PPA and NPA, whilst in 28 smear-negative cases, PPA and NPA were 89.3% and 98.6%, respectively. On average, positive culture results were available after 15.2 days of incubation (range, 5–42 days) versus 24 h for Xpert Ultra. Xpert Ultra PCR cycle threshold values correlated strongly with AFB-smear grade and time-to-culture positivity.
Conclusion. Xpert Ultra performed on specimens collected via bronchoscopy demonstrated excellent agreement with culture, even in smear-negative cases. Our results support the use of the Ultra on bronchoscopy specimens for accurate and rapid TB diagnosis in a low-incidence setting.
-
-
-
Predictors for true Actinomyces bacteraemia
More LessIntroduction. Actinomyces species colonizing the human oropharynx and gastrointestinal and urogenital tract are associated with a wide range of infections. The isolation of Actinomyces spp. from sterile clinical samples is regarded as significant.
Gap Statement. Increased use of advanced diagnostics has caused an increased detection of Actinomyces in the bloodstream, the clinical significance of which is unclear.
Aim. To investigate the clinical factors associated with true Actinomyces bacteraemia that could aid in differentiating it from transient Actinomyces bacteraemia.
Methodology. We conducted a retrospective study of all inpatients with Actinomyces bacteraemia from two tertiary care centres from 1 January 2006 to 26 September 2021. Data were collected on demographic and clinical characteristics, comorbidities, primary source of infection and outcomes. True bacteraemia was defined as Actinomyces bacteraemia with systemic manifestations of infection.
Results. A total of 82 cases of positive blood cultures were identified, of which 33 (40.2%) were true bacteraemia, based on clinical criteria. Patients with true bacteraemia were more likely to be older (P=0.007), have chronic skin ulcers (P<0.001), have a history of central line placement within 3 months of their presentation (P=0.04), have had a fever within 72 h of admission (P=0.05) and have presented with an abscess (P<0.001) compared with patients with transient bacteraemia. True bacteraemia was more likely to be associated with positive tissue cultures (P=0.02) and an infectious disease consultation than transient bacteraemia. Skin and soft tissue (27.3%) was the most common source followed by intra-abdominal (21.1%). Among true bacteraemia, the most common species was Actinomyces meyeri with a ratio of 1:8 (transient versus true bacteraemia). All-cause mortality was 30.3% in patients with true bacteraemia compared with 4.1% in patients with transient bacteraemia (P<0.001).
Conclusion. Predictors of true Actinomyces bacteraemia included older age, fever within 72 h of admission, presence of abscess and chronic skin disease. Actinomyces species exhibit varying degrees of invasiveness, with A. meyeri potentially showing higher invasive potential. Better awareness and involvement of infectious disease specialists is recommended in determining the clinical significance of transient Actinomyces bacteraemia and can help implement antibiotic stewardship and patient safety and improve outcomes. Further research will help to identify the true importance of these isolates.
-
-
-
Differentially culturable Mycobacterium tuberculosis in cough-generated aerosols of patients with pulmonary tuberculosis DCTB in cough-generated aerosols
More LessIntroduction. While Mycobacterium tuberculosis cells in sputum in sputum have been studied extensively, little is known of their properties in exhaled aerosols.
Hypothesis. As differentially culturable tubercle bacteria (DCTB) are readily found in sputum, we hypothesized that DCTB might also be present in aerosols and potentially contribute to transmission.
Aim. To test cough aerosols from recently diagnosed pulmonary tuberculosis (TB) patients for DCTB.
Methodology. Cough-generated aerosols and sputum samples were collected from active pulmonary TB patients (n=27). A cough aerosol sampling system was modified to include both an Andersen Cascade Impactor using solid agar and a BioSampler liquid impactor. We performed the most probable number of assays to detect DCTB, using media supplemented with Mycobacterium tuberculosis culture filtrate (CF).
Results. Briefly, 63% of patients (n=17) had advanced TB, and 55.6% (n=15) had a 3+ sputum smear for acid-fast bacilli. Evidence for DCTB was found in 8 patients’ aerosols (29.5%) and more than half of the 19 sputum samples tested (n=10; 52.6%). Two patients had DCTB in only one of the collected samples (cough aerosols or sputum). Among cough aerosol specimens, two patients (7%) only had CF-dependent DCTB.
Conclusion. We detected DCTB in sputum and evidence for their presence in cough samples from pulmonary TB patients. These data suggest that bacilli undetected by traditional mycobacterial cultures may be aerosolized from pulmonary TB patients.
-
-
-
Assessing the impact of common pain medications on gut microbiota composition and metabolites: insights from a Mendelian randomization study
More LessIntroduction. The relationship between analgesic use and gut microbiota alterations has garnered increasing attention. However, the causal link between these two factors remains to be elucidated. Given the prevalence of analgesic use and the significant role of gut microbiota in human health, clarifying this relationship is of great importance.
Hypothesis/Gap Statement. Existing observational studies are limited in their ability to establish causality between analgesic use and gut microbiota alterations. Therefore, there is a need for robust causal inference methods to explore this relationship and uncover the underlying mechanisms.
Aim. This study aims to investigate the causal associations between genetic susceptibility to four common analgesics (NSAIDs, salicylic acid, opioids, and anilides) and gut microbiota composition, as well as circulating metabolites, using a two-sample Mendelian randomization approach.
Methodology. A two-sample Mendelian randomization was used to investigate the potential association between genetic susceptibility to four analgesic uses and gut microbiota composition, as well as circulating metabolites. Summary-level statistics of genome-wide association studies were obtained from primarily European ancestry cohorts, including 466,457 participants from the UK Biobank and 18,340 individuals from the MiBioGen consortium.
Results. Only one suggestive causal association was found between NSAID use and elevated abundance of gut microbiota, namely group Eubacterium xylanophilum. In addition, salicylic use was correlated with an increased abundance of the family Prevotellaceae (P=0.006), while it was negatively associated with the abundance of 8 microbiota traits, including genus Clostridiumsensustricto1, Adlercreutzia, Akkermansia, family Clostridiaceae1, Verrucomicrobiaceae, phylum Verrucomicrobia, class Verrucomicrobiae and order Verrucomicrobiales with P value ranging from 0.009 to 0.043. No clear evidence was found between opioid and anilide use and gut microbiota alteration. Meanwhile, salicylic use was potentially causally associated with four metabolites, including acetoacetate, creatinine, omega-3 fatty acids and triglycerides in very large high-density lipoprotein, with P values ranging from 0.005 to 0.046.
Conclusion. The results of this study offer powerful evidence that the long-term use of salicylic acid may substantially impact gut microbiota composition and circulating metabolites. Further investigations are needed to uncover the underlying mechanisms.
-
- Molecular and Microbial Epidemiology
-
-
-
Enhanced laboratory surveillance study of Campylobacter species in England
More LessIntroduction. Campylobacteriosis is the leading cause of gastroenteritis worldwide, and Campylobacter species are the most frequently reported zoonotic, bacterial foodborne pathogens in England.
Gap statement. Currently, less than 2.0% of Campylobacter isolates in England undergo strain identification and typing, resulting in limited insight into their molecular epidemiology.
Aim. To assess the feasibility of using high-throughput whole-genome sequencing (WGS) to generate data for microbiological and epidemiological analysis by the implementation of a 3-month enhanced laboratory surveillance for Campylobacter spp. in England, and to make recommendations for improving the current Campylobacter surveillance strategies.
Methodology. All diagnostic laboratories in England were encouraged to refer isolates of Campylobacter spp. for WGS over a 3-month period (7 June–31 August 2021).
Results. Over 6,000 Campylobacter species isolates were characterized, of which 87.5% were successfully identified as Campylobacter jejuni and 8.1% as Campylobacter coli. Just over half of the isolates were referred from patients who were male (53%), and C. coli isolates tended to be from older patients than C. jejuni, with median ages of 55 and 44 years, respectively. The most common multi-locus sequencing type clonal complex identified was ST-21, and within this, the sequencing type ST6175 was the most frequently identified, of which 96.8% were predicted to carry antimicrobial resistance determinants, inferring reduced susceptibility to both ciprofloxacin and tetracycline. The four largest C. jejuni 5-single nucleotide polymorphism (SNP) clusters, associated with the larger clonal complexes and sequence type groups (ST6175, ST48, ST6175 and ST5136), accounted for 23.8% (n=1,150/4,838) of SNP typable isolates. Conversely, 28.4% and 39.5% of isolates C. jejuni and C. coli, respectively, appeared to be sporadic, with each isolate assigned a unique SNP address at the 5-SNP level.
Conclusion. WGS enabled identification of genetically related clusters of Campylobacter isolates in almost real time and shows potential for monitoring of inferred antimicrobial resistance. However, unlocking its full potential requires referral of sufficient and representative isolates for sequencing with parallel epidemiological data collection.
-
-
- Pathogenesis, Virulence and Host Response
-
-
-
Hantaan virus activates Src family kinase and induces endothelial cell hyperpermeability via the TLR4/TRAF6 pathway
More LessIntroduction. Hantaan virus (HTNV) predominantly infects human vascular endothelial cells (ECs) and causes increased vascular permeability, triggering haemorrhagic fever with renal syndrome, mainly in Asia. Previous studies have shown that endothelial permeability is regulated in part by the break of cell–cell adherens junctions (AJs). However, the intracellular mechanisms by which HTNV induces EC hyperpermeability via AJs remain unclear.
Hypothesis. We hypothesize that HTNV activates TLR4, and its downstream TRAF6 interacts with SFK, leading to the phosphorylation of adhesion junction-associated proteins and increased cell permeability.
Aim. The present study aimed to investigate the molecular mechanism by which Src family kinases (SFKs) modulate AJs and affect permeability.
Methodology. Real-time PCR (RT-PCR) and Western blot were used to assess TLR4, TRAF6 and SFK expression; Western blot was used to analyse the protein expression of AJs; small interfering RNAs (siRNAs) were used to inhibit gene expression in the human umbilical vein endothelial cells (HUVECs) and the distribution of vascular endothelial cadherin (VE-cadherin) was observed by immunofluorescence.
Results. HUVECs infected by HTNV displayed a lower permeability after a siRNA knockdown of TLR4 (si-TLR4). Moreover, HTNV increased the expression of TRAF6 and the phosphorylation of Src and AJs. After siRNA knockdown of TRAF6 (si-TRAF6), a decrease in the phosphorylation of Src and VE-cadherin was observed in HTNV-infected ECs compared to that in siRNA controls.
Conclusion. These data, for the first time, indicated that HTNV-induced upregulation of AJ phosphorylation is regulated by the TLR4/TRAF6/SFK signalling pathway.
-
-
-
-
Molecular characterization of serotype and virulence genes of Pseudomonas aeruginosa isolated from patients admitted at two hospitals in Addis Ababa, Ethiopia
More LessIntroduction. Pseudomonas aeruginosa contains a wide range of extracellular and cell-associated virulence factors that support its pathogenesis. The most variable portion of lipopolysaccharide, O-polysaccharide, confers serogrouping and is crucial for virulence.
Gap Statement. Despite their importance, P. aeruginosa serotypes and associated virulence factors are not well described at the level of strains obtained from Ethiopian clinical samples.
Aim. To characterize the serotypes and virulence factors of P. aeruginosa isolates from patients admitted to two hospitals in Addis Ababa, Ethiopia.
Methodology. Whole-genome sequencing was performed to characterize genes responsible for serotypes and virulence factors.
Results. Eight distinct serotypes were identified, with O6 (50%) and O11 (14.1%) being the most common and O9 (1.6%) being the least common. Serotype O6 was the most frequent serotype in all infections, and the percentage of O11 (38.5%) was high in burn wound isolates. The percentage of multidrug resistance was 56.6%. High levels of resistance to ciprofloxacin (51.8%) and ceftazidime (50.6%) and low levels of resistance to ceftazidime-avibactam (4.8%) were observed. Multidrug-resistant phenotypes were more common for the O11 (88.9%) and O5 (66.7%) serotypes. There were four (6.3%) exoU+ strains and one (1.6%) exoU+exoS+ multidrug-resistant strain, all of which were O11 serotypes. The frequencies of toxA, exoY, pilA and exoT were 93.8%, 96.9%, 17.2% and 96.9 %, respectively.
Conclusion. This study showed the presence of highly virulent multidrug-resistant P. aeruginosa strains in Ethiopia, and continuous molecular surveillance is essential for monitoring the spread of these strains and creating efficient management strategies.
-
- Prevention, Therapy and Therapeutics
-
-
-
Topoisomerase inhibitory activity of ethanolic extracts from botanicals Coptis chinensis and Salvia officinalis
More LessIntroduction. DNA topoisomerases are essential enzymes that allow cells to effectively manage the topological states of DNA. Due to the ubiquitous nature of their functions, topoisomerases have become promising treatment targets for various conditions, ranging from microbial infections to cancer.
Hypothesis. The botanicals, Coptis chinensis (Chinese goldthread) and Salvia officinalis (common sage), are herbs that boast a long history of traditional use for their effectiveness in treating a myriad of health concerns, including microbial infections and cancer, which could be associated with topoisomerase inhibitory activity.
Aim. This study sought to evaluate the antimicrobial and anticancer properties of these botanical extracts and determine if this activity was due to the presence of anti-topoisomerase activity.
Methodology. Using various bacterial genera, vaccinia virus, cancerous cell lines and topoisomerase activity assays, the activity of these extracts was evaluated.
Results. This study demonstrated that ethanolic extracts of these botanicals had potent anti-Gram-positive bacterial activity, antiviral activity and anticancer activity. Furthermore, this activity likely correlated with the ability of the extracts to inhibit topoisomerases II and IV and for Salvia officinalis, topoisomerase I.
Conclusion. These results support the potential therapeutic value of C. chinensis and S. officinalis for the treatment of health concerns.
-
-
Volumes and issues
-
Volume 75 (2026)
-
Volume 74 (2025)
-
Volume 73 (2024)
-
Volume 72 (2023 - 2024)
-
Volume 71 (2022)
-
Volume 70 (2021)
-
Volume 69 (2020)
-
Volume 68 (2019)
-
Volume 67 (2018)
-
Volume 66 (2017)
-
Volume 65 (2016)
-
Volume 64 (2015)
-
Volume 63 (2014)
-
Volume 62 (2013)
-
Volume 61 (2012)
-
Volume 60 (2011)
-
Volume 59 (2010)
-
Volume 58 (2009)
-
Volume 57 (2008)
-
Volume 56 (2007)
-
Volume 55 (2006)
-
Volume 54 (2005)
-
Volume 53 (2004)
-
Volume 52 (2003)
-
Volume 51 (2002)
-
Volume 50 (2001)
-
Volume 49 (2000)
-
Volume 48 (1999)
-
Volume 47 (1998)
-
Volume 46 (1997)
-
Volume 45 (1996)
-
Volume 44 (1996)
-
Volume 43 (1995)
-
Volume 42 (1995)
-
Volume 41 (1994)
-
Volume 40 (1994)
-
Volume 39 (1993)
-
Volume 38 (1993)
-
Volume 37 (1992)
-
Volume 36 (1992)
-
Volume 35 (1991)
-
Volume 34 (1991)
-
Volume 33 (1990)
-
Volume 32 (1990)
-
Volume 31 (1990)
-
Volume 30 (1989)
-
Volume 29 (1989)
-
Volume 28 (1989)
-
Volume 27 (1988)
-
Volume 26 (1988)
-
Volume 25 (1988)
-
Volume 24 (1987)
-
Volume 23 (1987)
-
Volume 22 (1986)
-
Volume 21 (1986)
-
Volume 20 (1985)
-
Volume 19 (1985)
-
Volume 18 (1984)
-
Volume 17 (1984)
-
Volume 16 (1983)
-
Volume 15 (1982)
-
Volume 14 (1981)
-
Volume 13 (1980)
-
Volume 12 (1979)
-
Volume 11 (1978)
-
Volume 10 (1977)
-
Volume 9 (1976)
-
Volume 8 (1975)
-
Volume 7 (1974)
-
Volume 6 (1973)
-
Volume 5 (1972)
-
Volume 4 (1971)
-
Volume 3 (1970)
-
Volume 2 (1969)
-
Volume 1 (1968)
Most Read This Month